Checkpoint Therapeutics, Inc. (CKPT) Social Stream
Checkpoint Therapeutics Inc (CKPT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CKPT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 4 | $20 | $16 | $17.75 | $1.77 | 902.82% |
| 2022-01-25 | 4 | $26 | $16 | $20 | $1.77 | 1029.94% |
| 2022-01-26 | 4 | $26 | $18 | $21 | $1.77 | 1086.44% |
| 2022-03-29 | 4 | $26 | $18 | $22.5 | $1.77 | 1171.19% |
The Trend in the Analyst Price Target
CKPT's average price target has moved up $6.7 over the prior 30 weeks.
CKPT reports an average of 510.14% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-25 | 1 | 20 | 8 | 15.25 | 2.83 | 438.87% |
| 2021-07-17 | 4 | 20 | 8 | 15.80 | 2.74 | 476.64% |
| 2021-08-07 | 4 | 20 | 8 | 15.80 | 2.60 | 507.69% |
| 2021-11-08 | 4 | 20 | 16 | 17.75 | 4.45 | 298.88% |
| 2022-01-27 | 4 | 26 | 18 | 22.50 | 2.28 | 886.84% |
CKPT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
CKPT's average broker recommendation rating improved by 0.67 over the prior 13 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CKPT as an investment opportunity.
- In the context of all US stocks, Checkpoint Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 396.22% of them.
- To contextualize these metrics, consider that out of all US stocks, Checkpoint Therapeutics Inc's number of analysts covering the stock is higher than 76.32% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Checkpoint Therapeutics Inc's variance in analysts' estimates is lower than -18.92% of them.
- In the context of Healthcare stocks, Checkpoint Therapeutics Inc's average analyst price target is greater than 133.79% of them.
Stocks similar to Checkpoint Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CINC, CELU, and CDMO.
Is CKPT a Buy, Hold or Sell? See the POWR Ratings now!